AMLX
Price
$13.82
Change
-$0.06 (-0.43%)
Updated
Sep 25, 04:59 PM (EDT)
Capitalization
1.47B
41 days until earnings call
XOMAO
Price
$25.55
Change
-$0.10 (-0.39%)
Updated
Sep 25, 02:26 PM (EDT)
Capitalization
N/A
Interact to see
Advertisement

AMLX vs XOMAO

Header iconAMLX vs XOMAO Comparison
Open Charts AMLX vs XOMAOBanner chart's image
Amylyx Pharmaceuticals
Price$13.82
Change-$0.06 (-0.43%)
Volume$54.22K
Capitalization1.47B
XOMA
Price$25.55
Change-$0.10 (-0.39%)
Volume$290
CapitalizationN/A
AMLX vs XOMAO Comparison Chart in %
Loading...
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XOMAO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMLX vs. XOMAO commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a Buy and XOMAO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (AMLX: $13.82 vs. XOMAO: $25.55)
Brand notoriety: AMLX and XOMAO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMLX: 98% vs. XOMAO: 23%
Market capitalization -- AMLX: $1.47B vs. XOMAO: $0
AMLX [@Biotechnology] is valued at $1.47B. XOMAO’s [@Biotechnology] market capitalization is $0. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 0 FA rating(s) are green whileXOMAO’s FA Score has 1 green FA rating(s).

  • AMLX’s FA Score: 0 green, 5 red.
  • XOMAO’s FA Score: 1 green, 4 red.
According to our system of comparison, both AMLX and XOMAO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 4 TA indicator(s) are bullish while XOMAO’s TA Score has 4 bullish TA indicator(s).

  • AMLX’s TA Score: 4 bullish, 4 bearish.
  • XOMAO’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, XOMAO is a better buy in the short-term than AMLX.

Price Growth

AMLX (@Biotechnology) experienced а +4.30% price change this week, while XOMAO (@Biotechnology) price change was -0.51% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.01%. For the same industry, the average monthly price growth was +9.06%, and the average quarterly price growth was +48.80%.

Reported Earning Dates

AMLX is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+1.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMLX YTD gains are higher at: 265.608 vs. XOMAO (5.948). XOMAO has higher annual earnings (EBITDA): -305K vs. AMLX (-196.3M). AMLX has more cash in the bank: 181M vs. XOMAO (83.9M). AMLX has less debt than XOMAO: AMLX (5.96M) vs XOMAO (115M). XOMAO has higher revenues than AMLX: XOMAO (12.8M) vs AMLX (-249K).
AMLXXOMAOAMLX / XOMAO
Capitalization1.47BN/A-
EBITDA-196.3M-305K64,360%
Gain YTD265.6085.9484,466%
P/E Ratio2.69N/A-
Revenue-249K12.8M-2%
Total Cash181M83.9M216%
Total Debt5.96M115M5%
TECHNICAL ANALYSIS
Technical Analysis
AMLXXOMAO
RSI
ODDS (%)
Bearish Trend 2 days ago
79%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
22%
Momentum
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 2 days ago
21%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
30%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
20%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
17%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 8 days ago
21%
Declines
ODDS (%)
Bearish Trend 28 days ago
82%
Bearish Trend 2 days ago
23%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
8%
Aroon
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
17%
View a ticker or compare two or three
Interact to see
Advertisement
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XOMAO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
REQSX23.68N/A
N/A
Russell Inv Equity Income C
SOPYX33.26N/A
N/A
ClearBridge Dividend Strategy I
SCVNX37.67N/A
N/A
Allspring Small Company Value Inst
MXVHX7.18N/A
N/A
Empower Large Cap Value Instl
WWMCX11.92N/A
N/A
Westwood Quality Midcap Institutional

XOMAO and

Correlation & Price change

A.I.dvisor indicates that over the last year, XOMAO has been closely correlated with AMLX. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if XOMAO jumps, then AMLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XOMAO
1D Price
Change %
XOMAO100%
-0.41%
AMLX - XOMAO
68%
Closely correlated
-0.43%
NRSN - XOMAO
26%
Poorly correlated
-4.84%
NEVPF - XOMAO
24%
Poorly correlated
N/A
ATAI - XOMAO
24%
Poorly correlated
-5.83%
LTRN - XOMAO
23%
Poorly correlated
-5.46%
More